Lyell Immunopharma, Inc.
LYEL
Cena:
$ 17.46
+0.16 (0.92%)
Valuace
70
Růst
30
Zdraví
75
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| ARCH VENTURE MANAGEMENT, LLC | 3.2 mil | 19.00% | -3.41% | 9.62% | 2025-06-30 |
| GSK PLC | 1.5 mil | 8.85% | -0.76% | 5.06% | 2025-12-31 |
| MWG MANAGEMENT LTD. | 1.0 mil | 6.81% | 20.13% | 20.13% | 2025-09-30 |
| BLACKROCK INC. | 13.5 mil | 5.31% | 0.00% | 0.00% | 2021-06-30 |
| BLACKROCK FUNDING, INC. /DE | 13.3 mil | 5.18% | 0.00% | 0.00% | 2024-09-30 |
| FORESITE CAPITAL MANAGEMENT IV, LLC | 800.40 tis | 4.68% | -3.95% | 6.77% | 2025-06-30 |
| VANGUARD GROUP INC | 826.43 tis | 4.52% | 0.00% | 0.00% | 2025-06-30 |
| ORLAND PROPERTIES LTD | 754.70 tis | 4.42% | 1.33% | 5.67% | 2025-09-30 |
| ALMITAS CAPITAL LLC | 577.81 tis | 3.38% | -1.30% | 2.62% | 2025-06-30 |
| WUXI APPTEC CO., LTD. | 7.4 mil | 2.88% | 5.82% | 53.56% | 2023-12-31 |
| FORESITE CAPITAL MANAGEMENT V, LLC | 477.08 tis | 2.79% | -5.40% | 3.53% | 2025-06-30 |
| MILLENNIUM MANAGEMENT LLC | 458.91 tis | 2.68% | 0.00% | 0.00% | 2025-06-30 |
| VENBIO PARTNERS LLC | 337.70 tis | 1.98% | -2.39% | 2.41% | 2025-06-30 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 310.20 tis | 1.81% | 0.00% | 0.00% | 2025-09-30 |
| ALPHABET INC. | 293.26 tis | 1.72% | -0.20% | 0.15% | 2025-06-30 |
| BLACKROCK, INC. | 191.82 tis | 1.12% | 0.00% | 0.00% | 2025-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 166.98 tis | 0.98% | 0.00% | 0.00% | 2025-06-30 |
| SC CHINA HOLDING LTD | 152.30 tis | 0.89% | -0.20% | 0.00% | 2025-06-30 |
| MARSHALL WACE, LLP | 148.52 tis | 0.87% | 0.00% | 0.00% | 2025-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 116.41 tis | 0.68% | 0.00% | 0.00% | 2025-06-30 |
| GOLDMAN SACHS GROUP INC | 114.49 tis | 0.67% | 0.00% | 0.00% | 2025-12-31 |
| WOODLINE PARTNERS LP | 98.43 tis | 0.67% | 0.00% | 0.00% | 2025-06-30 |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 102.00 tis | 0.60% | 1.28% | 1.28% | 2026-03-31 |
| INVESCO LTD. | 98.65 tis | 0.54% | 0.00% | 0.00% | 2025-06-30 |
| MIC CAPITAL MANAGEMENT UK LLP | 87.03 tis | 0.51% | -0.11% | 0.50% | 2025-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 86.93 tis | 0.51% | 0.00% | 0.00% | 2026-03-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 85.97 tis | 0.50% | 0.00% | 0.00% | 2025-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 1.2 mil | 0.47% | 0.00% | 0.00% | 2024-03-31 |
| OPALEYE MANAGEMENT INC. | 79.10 tis | 0.46% | 0.21% | 0.21% | 2026-03-31 |
| STATE STREET CORP | 72.52 tis | 0.42% | 0.00% | 0.00% | 2025-06-30 |
| D. E. SHAW & CO., INC. | 966.27 tis | 0.38% | 0.00% | 0.00% | 2024-03-31 |
| JANE STREET GROUP, LLC | 63.89 tis | 0.37% | 0.00% | 0.00% | 2025-12-31 |
| ORBIMED ADVISORS LLC | 51.73 tis | 0.35% | 0.01% | 0.02% | 2025-06-30 |
| INVENOMIC CAPITAL MANAGEMENT LP | 871.53 tis | 0.34% | 0.04% | 0.10% | 2023-12-31 |
| MORGAN STANLEY | 56.15 tis | 0.33% | 0.00% | 0.00% | 2025-06-30 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 55.11 tis | 0.32% | 0.00% | 0.00% | 2025-12-31 |
| JOHNSON & JOHNSON | 54.89 tis | 0.30% | 0.13% | 0.30% | 2025-09-30 |
| DIMENSIONAL FUND ADVISORS LP | 47.89 tis | 0.28% | 0.00% | 0.00% | 2026-03-31 |
| RBF CAPITAL, LLC | 44.09 tis | 0.26% | -0.06% | 0.04% | 2025-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 641.17 tis | 0.25% | 0.00% | 0.00% | 2021-09-30 |
| IKARIAN CAPITAL, LLC | 41.08 tis | 0.24% | -0.03% | 0.07% | 2025-06-30 |
| CLEARSTEAD ADVISORS, LLC | 39.92 tis | 0.23% | 0.01% | 0.01% | 2026-03-31 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 577.32 tis | 0.23% | 0.00% | 0.00% | 2021-06-30 |
| HRT FINANCIAL LP | 569.02 tis | 0.22% | 0.00% | 0.00% | 2024-09-30 |
| DECHENG CAPITAL LLC | 595.47 tis | 0.20% | -0.47% | 1.33% | 2024-12-31 |
| BANK OF AMERICA CORP /DE/ | 33.32 tis | 0.19% | 0.00% | 0.00% | 2025-06-30 |
| UBS GROUP AG | 31.81 tis | 0.19% | 0.00% | 0.00% | 2025-06-30 |
| BANK OF NEW YORK MELLON CORP | 525.78 tis | 0.18% | 0.00% | 0.00% | 2021-09-30 |
| NORTHERN TRUST CORP | 30.28 tis | 0.18% | 0.00% | 0.00% | 2025-06-30 |
| CANADA PENSION PLAN INVESTMENT BOARD | 29.41 tis | 0.17% | 0.00% | 0.00% | 2025-06-30 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 24.42 tis | 0.17% | 0.00% | 0.00% | 2025-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 367.68 tis | 0.14% | 0.00% | 0.00% | 2024-06-30 |
| GSA CAPITAL PARTNERS LLP | 354.82 tis | 0.14% | 0.03% | 0.04% | 2023-09-30 |
| 23.02 tis | 0.13% | 0.00% | 0.00% | 2026-03-31 | |
| TWO SIGMA ADVISERS, LP | 391.20 tis | 0.13% | 0.00% | 0.00% | 2023-12-31 |
| WALLEYE CAPITAL LLC | 22.21 tis | 0.13% | 0.00% | 0.00% | 2026-03-31 |
| POINT72 ASSET MANAGEMENT, L.P. | 21.29 tis | 0.12% | 0.00% | 0.00% | 2025-12-31 |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 20.80 tis | 0.12% | 0.00% | 0.01% | 2025-06-30 |
| JUMP FINANCIAL, LLC | 20.12 tis | 0.12% | 0.01% | 0.01% | 2026-03-31 |
| SQUAREPOINT OPS LLC | 19.29 tis | 0.11% | 0.00% | 0.00% | 2026-03-31 |
| CLARIUS GROUP, LLC | 19.96 tis | 0.11% | 0.02% | 0.04% | 2025-06-30 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 18.00 tis | 0.11% | 0.00% | 0.01% | 2025-06-30 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 295.65 tis | 0.10% | 0.00% | 0.00% | 2024-06-30 |
| SWISS NATIONAL BANK | 247.40 tis | 0.10% | 0.00% | 0.00% | 2023-06-30 |
| AMERICAN CENTURY COMPANIES INC | 15.97 tis | 0.09% | 0.00% | 0.00% | 2026-03-31 |
| BARCLAYS PLC | 15.97 tis | 0.09% | 0.00% | 0.00% | 2025-06-30 |
| EXCHANGE TRADED CONCEPTS, LLC | 246.35 tis | 0.08% | 0.00% | 0.00% | 2023-06-30 |
| ENTRYPOINT CAPITAL, LLC | 208.00 tis | 0.08% | 0.16% | 0.16% | 2023-12-31 |
| RHUMBLINE ADVISERS | 235.69 tis | 0.08% | 0.00% | 0.00% | 2021-09-30 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 13.44 tis | 0.08% | 0.00% | 0.00% | 2026-03-31 |
| ACADIAN ASSET MANAGEMENT LLC | 11.39 tis | 0.08% | 0.00% | 0.00% | 2025-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 13.13 tis | 0.08% | 0.00% | 0.00% | 2025-06-30 |
| UBS ASSET MANAGEMENT AMERICAS INC | 192.61 tis | 0.08% | 0.00% | 0.00% | 2023-09-30 |
| ALLIANCEBERNSTEIN L.P. | 220.79 tis | 0.07% | 0.00% | 0.00% | 2022-03-31 |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC | 183.81 tis | 0.07% | 0.00% | 0.00% | 2023-03-31 |
| CITADEL ADVISORS LLC | 12.00 tis | 0.07% | 0.00% | 0.00% | 2026-03-31 |
| TREXQUANT INVESTMENT LP | 10.28 tis | 0.07% | 0.00% | 0.00% | 2025-09-30 |
| CAXTON ASSOCIATES LP | 174.66 tis | 0.07% | 0.02% | 0.02% | 2023-06-30 |
| TWO SIGMA INVESTMENTS, LP | 11.59 tis | 0.07% | 0.00% | 0.00% | 2025-06-30 |
| RANGELEY CAPITAL, LLC | 10.00 tis | 0.07% | 0.14% | 0.14% | 2025-09-30 |
| AQR CAPITAL MANAGEMENT LLC | 174.28 tis | 0.06% | 0.00% | 0.00% | 2023-09-30 |
| PRUDENTIAL FINANCIAL INC | 144.96 tis | 0.06% | 0.00% | 0.00% | 2022-03-31 |
| BAILLIE GIFFORD & CO | 141.95 tis | 0.06% | 0.00% | 0.00% | 2021-06-30 |
| BOOTHBAY FUND MANAGEMENT, LLC | 9.52 tis | 0.05% | 0.00% | 0.00% | 2025-06-30 |
| VESTAL POINT CAPITAL, LP | 130.00 tis | 0.05% | 0.02% | 0.02% | 2024-03-31 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 128.20 tis | 0.05% | 0.00% | 0.00% | 2024-03-31 |
| SHELL ASSET MANAGEMENT CO | 127.99 tis | 0.05% | 0.01% | 0.01% | 2024-09-30 |
| LEGAL & GENERAL GROUP PLC | 127.62 tis | 0.05% | 0.00% | 0.00% | 2021-06-30 |
| CREDIT SUISSE AG/ | 123.26 tis | 0.05% | 0.00% | 0.00% | 2022-09-30 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 123.00 tis | 0.05% | 0.01% | 0.01% | 2024-03-31 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 122.49 tis | 0.05% | 0.00% | 0.00% | 2021-09-30 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 8.51 tis | 0.05% | 0.00% | 0.00% | 2025-12-31 |
| RAYMOND JAMES FINANCIAL INC | 7.90 tis | 0.04% | 0.00% | 0.00% | 2025-06-30 |
| INTECH INVESTMENT MANAGEMENT LLC | 124.70 tis | 0.04% | 0.00% | 0.00% | 2024-09-30 |
| TUDOR INVESTMENT CORP ET AL | 124.32 tis | 0.04% | 0.00% | 0.00% | 2024-03-31 |
| CANDRIAM S.C.A. | 7.62 tis | 0.04% | 0.00% | 0.00% | 2025-12-31 |
| MARINER, LLC | 99.31 tis | 0.04% | 0.00% | 0.00% | 2022-12-31 |
| FRANKLIN RESOURCES INC | 98.65 tis | 0.04% | 0.00% | 0.00% | 2023-06-30 |
| CORNERCAP INVESTMENT COUNSEL INC | 96.29 tis | 0.04% | -0.01% | 0.02% | 2023-03-31 |
| BBR PARTNERS, LLC | 6.83 tis | 0.04% | 0.01% | 0.01% | 2025-12-31 |
| STATE OF WISCONSIN INVESTMENT BOARD | 90.16 tis | 0.04% | 0.00% | 0.00% | 2023-06-30 |
| CITIGROUP INC | 5.91 tis | 0.03% | 0.00% | 0.00% | 2025-06-30 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 85.46 tis | 0.03% | 0.00% | 0.00% | 2021-09-30 |
| DEUTSCHE BANK AG\ | 82.44 tis | 0.03% | 0.00% | 0.00% | 2021-09-30 |
| COREBRIDGE FINANCIAL, INC. | 79.89 tis | 0.03% | 0.00% | 0.00% | 2024-06-30 |
| VANGUARD GLOBAL ADVISERS, LLC | 5.17 tis | 0.03% | 0.00% | 0.00% | 2026-03-31 |
| ROYAL BANK OF CANADA | 4.19 tis | 0.03% | 0.00% | 0.00% | 2025-09-30 |
| XTX TOPCO LTD | 70.17 tis | 0.03% | -0.02% | 0.01% | 2022-12-31 |
| DIADEMA PARTNERS LP | 4.10 tis | 0.02% | -0.01% | 0.01% | 2025-12-31 |
| VOYA INVESTMENT MANAGEMENT LLC | 58.59 tis | 0.02% | 0.00% | 0.00% | 2022-06-30 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 3.77 tis | 0.02% | 0.00% | 0.01% | 2025-06-30 |
| FMR LLC | 2.72 tis | 0.02% | 0.00% | 0.00% | 2025-06-30 |
| TD ASSET MANAGEMENT INC | 50.23 tis | 0.02% | 0.00% | 0.00% | 2025-06-30 |
| TAKEDA PHARMACEUTICAL CO LTD | 41.17 tis | 0.01% | -0.87% | 1.86% | 2024-12-31 |
| JONES FINANCIAL COMPANIES LLLP | 2.00 tis | 0.01% | 0.00% | 0.00% | 2025-06-30 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 39.62 tis | 0.01% | 0.00% | 0.00% | 2025-06-30 |
| WELLS FARGO & COMPANY/MN | 1.97 tis | 0.01% | 0.00% | 0.00% | 2025-06-30 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 1.86 tis | 0.01% | 0.00% | 0.00% | 2025-06-30 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.74 tis | 0.01% | 0.00% | 0.00% | 2025-06-30 |
| ADVISORS ASSET MANAGEMENT, INC. | 0.57 tis | 0.00% | 0.00% | 0.00% | 2025-06-30 |
| JPMORGAN CHASE & CO | 0.49 tis | 0.00% | 0.00% | 0.00% | 2025-06-30 |
| GF FUND MANAGEMENT CO. LTD. | 0.41 tis | 0.00% | 0.00% | 0.00% | 2025-09-30 |
| BNP PARIBAS ARBITRAGE, SNC | 0.36 tis | 0.00% | 0.00% | 0.00% | 2025-06-30 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Shah Smital | 0 | 0.00 | 16.3 2026 | 0 | ||
| Shah Smital | officer: Chief Fin. and Bus. Officer | A-Award | 140000 | 25.50 | 16.3 2026 | 140000 |
| ARCH Venture Fund XIII, L.P. | 10 percent owner | P-Purchase | 488090 | 25.61 | 9.3 2026 | 1426528 |
| ARCH Venture Partners IX, LLC | 10 percent owner | P-Purchase | 488090 | 25.61 | 9.3 2026 | 1426528 |
| Lee Gary K. | officer: Chief Scientific Officer | S-Sale | 1671 | 23.39 | 12.2 2026 | 16938 |
| Hill Stephen J. | officer: Chief Operating Officer | S-Sale | 1236 | 23.39 | 12.2 2026 | 17795 |
| Seely Lynn | director, officer: President and CEO | S-Sale | 7455 | 23.39 | 12.2 2026 | 74266 |
| Shook David | officer: Chief Medical Officer | A-Award | 50000 | 23.71 | 11.2 2026 | 50000 |
| Bulis Veronica Sanchez | officer: VP, Corporate Controller | S-Sale | 254 | 23.12 | 11.2 2026 | 15637 |
| Bulis Veronica Sanchez | officer: VP, Corporate Controller | A-Award | 8750 | 0.00 | 11.2 2026 | 15891 |
| Meltz Mark A | officer: General Counsel | A-Award | 50000 | 23.71 | 11.2 2026 | 50000 |
| Seely Lynn | director, officer: President and CEO | S-Sale | 438 | 23.12 | 11.2 2026 | 81721 |
| Seely Lynn | director, officer: President and CEO | A-Award | 20000 | 0.00 | 11.2 2026 | 82159 |
| Seely Lynn | director, officer: President and CEO | A-Award | 155000 | 23.71 | 11.2 2026 | 155000 |
| Lee Gary K. | officer: Chief Scientific Officer | S-Sale | 147 | 23.12 | 11.2 2026 | 18609 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 4000 | 0.00 | 11.2 2026 | 18756 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 50000 | 23.71 | 11.2 2026 | 50000 |
| Hill Stephen J. | officer: Chief Operating Officer | S-Sale | 109 | 23.12 | 11.2 2026 | 19031 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 4000 | 0.00 | 11.2 2026 | 19140 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 65000 | 23.71 | 11.2 2026 | 65000 |
| Bulis Veronica Sanchez | officer: VP, Corporate Controller | S-Sale | 936 | 32.32 | 6.1 2026 | 7141 |
| Bulis Veronica Sanchez | officer: VP, Corporate Controller | S-Sale | 1136 | 38.67 | 6.1 2026 | 8077 |
| Hill Stephen J. | officer: Chief Operating Officer | S-Sale | 95 | 16.12 | 12.11 2025 | 15750 |
| Lee Gary K. | officer: Chief Scientific Officer | S-Sale | 138 | 16.16 | 12.11 2025 | 15366 |
| Bulis Veronica Sanchez | officer: VP, Corporate Controller | S-Sale | 239 | 16.10 | 12.11 2025 | 9213 |
| Seely Lynn | director, officer: President and CEO | S-Sale | 412 | 16.11 | 12.11 2025 | 67159 |
| Bulis Veronica Sanchez | officer: VP, Corporate Controller | 3000 | 37.40 | 10.11 2025 | 0 | |
| Bulis Veronica Sanchez | officer: VP, Corporate Controller | 1674 | 42.60 | 10.11 2025 | 0 | |
| Bulis Veronica Sanchez | officer: VP, Corporate Controller | 0 | 0.00 | 10.11 2025 | 9452 | |
| Seely Lynn | director, officer: President and CEO | A-Award | 175000 | 17.23 | 29.10 2025 | 175000 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 68000 | 17.23 | 29.10 2025 | 68000 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 75000 | 17.23 | 29.10 2025 | 75000 |
| Lee Gary K. | officer: Chief Scientific Officer | S-Sale | 1453 | 10.54 | 22.8 2025 | 15504 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 8000 | 0.00 | 22.8 2025 | 16957 |
| Newton Charles W. | officer: Chief Financial Officer | S-Sale | 1453 | 10.54 | 22.8 2025 | 15306 |
| Newton Charles W. | officer: Chief Financial Officer | A-Award | 8000 | 0.00 | 22.8 2025 | 16759 |
| Hill Stephen J. | officer: Chief Operating Officer | S-Sale | 1004 | 10.54 | 22.8 2025 | 15845 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 8000 | 0.00 | 22.8 2025 | 16849 |
| Seely Lynn | director, officer: President and CEO | S-Sale | 7257 | 10.54 | 22.8 2025 | 67571 |
| Seely Lynn | director, officer: President and CEO | A-Award | 40000 | 0.00 | 22.8 2025 | 74828 |
| Newton Charles W. | officer: Chief Financial Officer | S-Sale | 136 | 10.34 | 13.8 2025 | 8759 |
| Newton Charles W. | officer: Chief Financial Officer | S-Sale | 131 | 10.53 | 13.8 2025 | 8895 |
| Lee Gary K. | officer: Chief Scientific Officer | S-Sale | 136 | 10.34 | 13.8 2025 | 8957 |
| Lee Gary K. | officer: Chief Scientific Officer | S-Sale | 131 | 10.53 | 13.8 2025 | 9093 |
| Hill Stephen J. | officer: Chief Operating Officer | S-Sale | 94 | 10.34 | 13.8 2025 | 8849 |
| Hill Stephen J. | officer: Chief Operating Officer | S-Sale | 91 | 10.53 | 13.8 2025 | 8943 |
| Seely Lynn | director, officer: President and CEO | S-Sale | 406 | 10.34 | 13.8 2025 | 34828 |
| Seely Lynn | director, officer: President and CEO | S-Sale | 391 | 10.53 | 13.8 2025 | 35234 |
| ARCH Venture Fund XIII, L.P. | 10 percent owner | 0 | 0.00 | 29.7 2025 | 938438 | |
| ARCH Venture Partners IX, LLC | 10 percent owner: | 0 | 0.00 | 29.7 2025 | 0 | |
| Shook David | 0 | 0.00 | 11.6 2025 | 0 | ||
| Meltz Mark A | 0 | 0.00 | 11.6 2025 | 0 | ||
| Bachleda Mark | 0 | 0.00 | 11.6 2025 | 0 | ||
| Shook David | officer: Chief Medical Officer | A-Award | 21900 | 0.00 | 11.6 2025 | 21900 |
| Shook David | officer: Chief Medical Officer | A-Award | 43750 | 12.47 | 11.6 2025 | 43750 |
| Meltz Mark A | officer: General Counsel | A-Award | 100000 | 12.47 | 11.6 2025 | 100000 |
| Bachleda Mark | director | A-Award | 13000 | 12.47 | 11.6 2025 | 13000 |
| Ramachandra Sumant | director | A-Award | 130000 | 0.40 | 19.5 2025 | 130000 |
| NABEL ELIZABETH G | director | A-Award | 130000 | 0.40 | 19.5 2025 | 130000 |
| BRAWLEY OTIS W | director | A-Award | 130000 | 0.40 | 19.5 2025 | 130000 |
| FRIEDMAN CATHY | director | A-Award | 130000 | 0.40 | 19.5 2025 | 130000 |
| RIEFLIN WILLIAM JL | director | A-Award | 130000 | 0.40 | 19.5 2025 | 130000 |
| Klausner Richard | director | A-Award | 130000 | 0.40 | 19.5 2025 | 130000 |
| BRAWLEY OTIS W | director | P-Purchase | 35640 | 0.56 | 2.4 2025 | 35640 |
| Ramachandra Sumant | director | P-Purchase | 200000 | 0.58 | 25.3 2025 | 200000 |
| Seely Lynn | director, officer: President and CEO | P-Purchase | 175000 | 0.61 | 18.3 2025 | 712500 |
| Newton Charles W. | officer: Chief Financial Officer | P-Purchase | 200000 | 0.56 | 18.3 2025 | 200000 |
| Klausner Richard | director | P-Purchase | 158000 | 0.60 | 18.3 2025 | 843365 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 56250 | 0.55 | 26.2 2025 | 56250 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 112500 | 0.00 | 26.2 2025 | 176696 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 450000 | 0.55 | 26.2 2025 | 450000 |
| Newton Charles W. | officer: Chief Financial Officer | A-Award | 56250 | 0.55 | 26.2 2025 | 56250 |
| Newton Charles W. | officer: Chief Financial Officer | A-Award | 112500 | 0.00 | 26.2 2025 | 172725 |
| Newton Charles W. | officer: Chief Financial Officer | A-Award | 450000 | 0.55 | 26.2 2025 | 450000 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 56250 | 0.55 | 26.2 2025 | 56250 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 112500 | 0.00 | 26.2 2025 | 172899 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 450000 | 0.55 | 26.2 2025 | 450000 |
| Seely Lynn | director, officer: President and CEO | A-Award | 168750 | 0.55 | 26.2 2025 | 168750 |
| Seely Lynn | director, officer: President and CEO | A-Award | 337500 | 0.00 | 26.2 2025 | 537500 |
| Seely Lynn | director, officer: President and CEO | A-Award | 1350000 | 0.55 | 26.2 2025 | 1350000 |
| Lang Matthew | officer: Chief Business Officer | A-Award | 56250 | 0.55 | 26.2 2025 | 56250 |
| Lang Matthew | officer: Chief Business Officer | A-Award | 112500 | 0.00 | 26.2 2025 | 162500 |
| Lang Matthew | officer: Chief Business Officer | A-Award | 450000 | 0.55 | 26.2 2025 | 450000 |
| Ramachandra Sumant | 0 | 0.00 | 1.11 2024 | 0 | ||
| Ramachandra Sumant | director | A-Award | 260000 | 0.96 | 1.11 2024 | 260000 |
| FRIEDMAN CATHY | director | A-Award | 130000 | 2.36 | 17.6 2024 | 130000 |
| BRAWLEY OTIS W | director | A-Award | 130000 | 2.36 | 17.6 2024 | 130000 |
| NABEL ELIZABETH G | director | A-Award | 130000 | 2.36 | 17.6 2024 | 130000 |
| RIEFLIN WILLIAM JL | director | A-Award | 130000 | 2.36 | 17.6 2024 | 130000 |
| Klausner Richard | director | A-Award | 130000 | 2.36 | 17.6 2024 | 130000 |
| Bishop Hans Edgar | director | A-Award | 130000 | 2.36 | 17.6 2024 | 130000 |
| NELSEN ROBERT | director, 10 percent owner: | A-Award | 130000 | 2.36 | 17.6 2024 | 130000 |
| Newton Charles W. | officer: Chief Financial Officer | A-Award | 40000 | 0.00 | 13.2 2024 | 48729 |
| Newton Charles W. | officer: Chief Financial Officer | A-Award | 400000 | 1.80 | 13.2 2024 | 400000 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 40000 | 0.00 | 13.2 2024 | 52700 |
| Lee Gary K. | officer: Chief Scientific Officer | A-Award | 400000 | 1.80 | 13.2 2024 | 400000 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 40000 | 0.00 | 13.2 2024 | 48928 |
| Hill Stephen J. | officer: Chief Operating Officer | A-Award | 400000 | 1.80 | 13.2 2024 | 400000 |
| Lang Matthew | officer: Chief Business Officer | A-Award | 50000 | 0.00 | 13.2 2024 | 50000 |
| Lang Matthew | officer: Chief Business Officer | A-Award | 500000 | 1.80 | 13.2 2024 | 500000 |
